Antiresorptivedrug-related osteonecrosis of jaw (ARONJ); terms MRONJ & ARONJ preferred over others
Bisphosphonate-related osteonecrosis of jaw (BRONJ)
Denosumab-related osteonecrosis of jaw (DRONJ)
Definitions
Medication-related exposed bone, or bone that can be probed through intraoral or extraoral fistula in maxillofacial region, persisting > 8 weeks
No history of prior craniofacial radiation therapy
Induced by antiresorptive drugs, such as bisphosphonates (BP) & denosumab, & antiangiogenics, such as bevacizumab, sunitinib
IMAGING
General Features
Radiographic Findings
CT Findings
MR Findings
Imaging Recommendations
Nuclear Medicine Findings
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Gross Pathologic & Surgical Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Image Interpretation Pearls
Reporting Tips
Selected References
AlDhalaan NA et al: Medication-related osteonecrosis of the jaw: a review. Cureus. 12(2):e6944, 2020
Li J et al: Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw. J Stomatol Oral Maxillofac Surg. 121(3):264-7, 2020
Limones A et al: Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 25(3):e326-36, 2020
Ottesen C et al: Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon. 6(4):e03795, 2020
Bodem JP et al: Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III. Oral Surg Oral Med Oral Pathol Oral Radiol. 121(4):367-72, 2016
Kim HJ et al: Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases. Maxillofac Plast Reconstr Surg. 38(1):6, 2016
Kämmerer PW et al: Surgical evaluation of panoramic radiography and cone beam computed tomography for therapy planning of bisphosphonate-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 121(4):419-24, 2016
Melville JC et al: A technique for the treatment of oral-antral fistulas resulting from medication-related osteonecrosis of the maxilla: the combined buccal fat pad flap and radical sinusotomy. Oral Surg Oral Med Oral Pathol Oral Radiol. 122(3):287-91, 2016
Rollason V et al: Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst Rev. 2:CD008455, 2016
Taguchi A et al: Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw. Curr Med Res Opin. 32(7):1261-8, 2016
Krstevska S et al: Osteonecrosis of the jaw after bisphosphonates treatment in patients with multiple myeloma. Med Arch. 69(6):367-70, 2015
Bedogni A et al: Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review. J Oral Maxillofac Surg. 68(7):1662-6, 2010
Chiu CT et al: Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis. J Oral Maxillofac Surg. 68(5):1055-63, 2010
Filleul O et al: Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol. 136(8):1117-24, 2010
Kyrgidis A et al: Dental extractions in patients receiving bisphosphonate therapy. J Oral Maxillofac Surg. 68(7):1704-6; author reply 1706, 2010
Lazarovici TS et al: Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg. 68(4):790-6, 2010
Lo JC et al: Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 68(2):243-53, 2010
Saia G et al: Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg. 68(4):797-804, 2010
Setabutr D et al: Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw. Am J Otolaryngol. 31(2):127-9, 2010
Yarom N et al: Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw? J Oral Maxillofac Surg. 68(3):705, 2010
Arrain Y et al: Bisphosphonates and osteonecrosis of the jaw--current thoughts. Dent Update. 36(7):415-9, 2009
Kyrgidis A et al: Bisphosphonate osteonecrosis of the jaws in cancer patients. Breast. 18(5):335, 2009
Morag Y et al: Bisphosphonate-related osteonecrosis of the jaw: a pictorial review. Radiographics. 29(7):1971-84, 2009
Related Anatomy
Loading...
Related Differential Diagnoses
Loading...
References
Tables
Tables
KEY FACTS
Terminology
Imaging
Top Differential Diagnoses
Clinical Issues
Diagnostic Checklist
TERMINOLOGY
Abbreviations
Medication-related osteonecrosis of jaw (MRONJ)
Synonyms
Antiresorptivedrug-related osteonecrosis of jaw (ARONJ); terms MRONJ & ARONJ preferred over others
Bisphosphonate-related osteonecrosis of jaw (BRONJ)
Denosumab-related osteonecrosis of jaw (DRONJ)
Definitions
Medication-related exposed bone, or bone that can be probed through intraoral or extraoral fistula in maxillofacial region, persisting > 8 weeks
No history of prior craniofacial radiation therapy
Induced by antiresorptive drugs, such as bisphosphonates (BP) & denosumab, & antiangiogenics, such as bevacizumab, sunitinib
IMAGING
General Features
Radiographic Findings
CT Findings
MR Findings
Imaging Recommendations
Nuclear Medicine Findings
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Gross Pathologic & Surgical Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Image Interpretation Pearls
Reporting Tips
Selected References
AlDhalaan NA et al: Medication-related osteonecrosis of the jaw: a review. Cureus. 12(2):e6944, 2020
Li J et al: Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw. J Stomatol Oral Maxillofac Surg. 121(3):264-7, 2020
Limones A et al: Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 25(3):e326-36, 2020
Ottesen C et al: Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon. 6(4):e03795, 2020
Bodem JP et al: Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III. Oral Surg Oral Med Oral Pathol Oral Radiol. 121(4):367-72, 2016
Kim HJ et al: Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases. Maxillofac Plast Reconstr Surg. 38(1):6, 2016
Kämmerer PW et al: Surgical evaluation of panoramic radiography and cone beam computed tomography for therapy planning of bisphosphonate-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 121(4):419-24, 2016
Melville JC et al: A technique for the treatment of oral-antral fistulas resulting from medication-related osteonecrosis of the maxilla: the combined buccal fat pad flap and radical sinusotomy. Oral Surg Oral Med Oral Pathol Oral Radiol. 122(3):287-91, 2016
Rollason V et al: Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst Rev. 2:CD008455, 2016
Taguchi A et al: Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw. Curr Med Res Opin. 32(7):1261-8, 2016
Krstevska S et al: Osteonecrosis of the jaw after bisphosphonates treatment in patients with multiple myeloma. Med Arch. 69(6):367-70, 2015
Bedogni A et al: Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review. J Oral Maxillofac Surg. 68(7):1662-6, 2010
Chiu CT et al: Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis. J Oral Maxillofac Surg. 68(5):1055-63, 2010
Filleul O et al: Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol. 136(8):1117-24, 2010
Kyrgidis A et al: Dental extractions in patients receiving bisphosphonate therapy. J Oral Maxillofac Surg. 68(7):1704-6; author reply 1706, 2010
Lazarovici TS et al: Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg. 68(4):790-6, 2010
Lo JC et al: Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 68(2):243-53, 2010
Saia G et al: Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg. 68(4):797-804, 2010
Setabutr D et al: Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw. Am J Otolaryngol. 31(2):127-9, 2010
Yarom N et al: Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw? J Oral Maxillofac Surg. 68(3):705, 2010
Arrain Y et al: Bisphosphonates and osteonecrosis of the jaw--current thoughts. Dent Update. 36(7):415-9, 2009
Kyrgidis A et al: Bisphosphonate osteonecrosis of the jaws in cancer patients. Breast. 18(5):335, 2009
Morag Y et al: Bisphosphonate-related osteonecrosis of the jaw: a pictorial review. Radiographics. 29(7):1971-84, 2009
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.